Malaga Cove Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Sell
3,181
-8
-0.3% -$3.84K 0.51% 55
2026
Q1
$1.57M Buy
3,189
+90
+3% +$48.8K 0.56% 51
2025
Q4
$1.8M Sell
3,099
-138
-4% -$78K 0.62% 46
2025
Q3
$1.57M Sell
3,237
-82
-2% -$38.2K 0.57% 51
2025
Q2
$1.35M Buy
3,319
+827
+33% +$346K 0.53% 53
2025
Q1
$1.24M Buy
2,492
+770
+45% +$417K 0.54% 54
2024
Q4
$896K Buy
1,722
+621
+56% +$341K 0.35% 74
2024
Q3
$681K Buy
1,101
+10
+0.9% +$5.92K 0.27% 93
2024
Q2
$603K Hold
1,091
0.25% 103
2024
Q1
$634K Hold
1,091
0.26% 103
2023
Q4
$579K Buy
1,091
+299
+38% +$145K 0.24% 105
2023
Q3
$401K Buy
792
+360
+83% +$192K 0.19% 125
2023
Q2
$225K Buy
+432
New +$233K 0.1% 145
2014
Q4
Sell
-4,161
Closed -$506K 100
2014
Q3
$506K Buy
+4,161
New +$506K 0.41% 44

Other funds holding TMO

Malaga Cove Capital's TMO Position: Q2 2026 in Review

Malaga Cove Capital reduced its Thermo Fisher Scientific (TMO) stake by 0.25% in Q2 2026, selling an estimated $3.84K and leaving 3,181 shares worth $1.59M. The position accounts for 0.51% of the portfolio, ranked #55.

Malaga Cove Capital first reported a position in TMO in Q3 2014 and has held it in 14 quarters since. The position peaked at $1.8M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Malaga Cove Capital held 3,181 shares of Thermo Fisher Scientific worth $1.59M as of Q2 2026.
  • Malaga Cove Capital sold 8 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.84K.
  • Thermo Fisher Scientific made up 0.51% of Malaga Cove Capital's portfolio in Q2 2026, its #55 holding.
  • Malaga Cove Capital first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 14 quarters since.
  • Malaga Cove Capital's Thermo Fisher Scientific position peaked at $1.8M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Malaga Cove Capital's 13F filing for Q2 2026, filed 24 Jul 2026.